Copenhagen K Copenhagen, 26 March 2025 ANNOUNCEMENT no.10/2025 CEMAT A/SCompany reg. (CVR) no. 24 93 28 18Annual general meeting 2025 On 26 March 2025 at 1:00 pm the annual general meeting was held in ...

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...

Aegon Ltd. today publishes its Integrated Annual Report 2024. The report also reflects on the key trends that influence Aegon's businesses and its stakeholders, and how these trends impact the way in ...

COPENHAGEN, DENMARK / ACCESS Newswire / March 27, 2025 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company" held its annual general meeting on 27 March 2025.To the shareholders of FluoGuide A/S.Th ...

Syensqo releases 2024 annual integrated report Brussels, Belgium - March 28, 2025 - 08:30 CET Syensqo has published its 2024 annual integrated report today giving its stakeholders a comprehensive ...

About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

Chapel Down Group plc ( ($GB:CDGP) ) has provided an update. Chapel Down Group Plc announced that it will publish its annual ...

The Media Financial Management Annual Conference will kick off its first full day of sessions with a welcome address from the ...

The presentation is open to all interested parties and may include forward-looking information. Please register in advance at the following link: https://cadeler-2024-annual-report-presentation ...

The oral presentation will feature updated clinical results from the BEXMAB study, including data previously presented at the ASH Annual Meeting ... for our authors to report on investments ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...